Type 1 diabetes

Serum adiponectin concentrations as a risk factor for cardiovascular complications in type 1 diabetes

Diabetes Res Clin PractPublished Cohort study

Authors' conclusion

Adiponectin may protect carotid atherosclerosis and peripheral artery disease in T1D. It may be associated with increased cardiovascular events, depending on cardiac structural changes.

Study context

Population
Participants with T1D in DCCT/EDIC; adiponectin measured in EDIC year 8
Participants
1,040 participants
Exposure
Adiponectin quartiles
Outcome
Peripheral artery disease (ankle brachial index)
Methodological detailsanalysis of DCCT/EDIC data, multivariable regression, Cox proportional hazards models
  • Analysis of DCCT/EDIC data
  • Multivariable regression
  • Cox proportional hazards models

Main finding

As reported in the abstract

Odds ratio (95% CI)
Q4vs Q1
0.22(0.07–0.72)
Q3vs Q1
0.48(0.18–1.25)
Q2vs Q1
0.38(0.14–0.99)

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)
Any cardiovascular eventsQ4vs Q1Associations diminished after adjustment for LVEDV index2.59 (1.10–6.06)
Any cardiovascular eventsQ3vs Q1Associations diminished after adjustment for LVEDV index2.03 (0.90–4.59)
Any cardiovascular eventsQ2vs Q1Associations diminished after adjustment for LVEDV index1.22 (0.52–2.85)
Major atherosclerotic cardiovascular eventsQ4vs Q1Associations diminished after adjustment for LVEDV index11.37 (2.04–63.43)
Major atherosclerotic cardiovascular eventsQ3vs Q1Associations diminished after adjustment for LVEDV index5.68 (1.04–31.07)
Major atherosclerotic cardiovascular eventsQ2vs Q1Associations diminished after adjustment for LVEDV index3.76 (0.65–21.77)

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Serum adiponectin concentrations as a risk factor for cardiovascular complications in type 1 diabetes. Diabetes Res Clin Pract. Published 10 May 2023. doi:10.1016/j.diabres.2023.110700

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.